CORESTEMCHEMON Inc. (KOSDAQ:166480)

South Korea · Delayed Price · Currency is KRW

2,410.00

-120.00 (-4.74%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Cell Therapy Pharmaceutical Sector		2.12B	5.49B	1.57B	2.21B	3.68B
Cell Therapy Pharmaceutical Sector Growth		-61.37%	249.27%	-29.00%	-39.85%	23.20%
Non-Clinical Trial Agency Division		32.02B	40.87B	29.14B	24.77B	20.91B
Non-Clinical Trial Agency Division Growth		-21.66%	40.25%	17.66%	18.42%	7.52%
Unallocated Adjustments		-480.00M	-480.00M	-471.40M	-623.13M	-310.00M
Total		33.66B	45.88B	30.24B	26.36B	24.28B
Total Growth		-26.64%	51.71%	14.73%	8.54%	8.82%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea		33.93B	45.88B	30.24B	26.36B	24.28B
South Korea Growth		-26.05%	51.71%	14.73%	8.54%	8.82%
Consolidation Adjustment		-480.00M	-	-	-	-
Asia		210.94M	-	-	-	-
Total		33.66B	45.88B	30.24B	26.36B	24.28B
Total Growth		-26.64%	51.71%	14.73%	8.54%	8.82%

Source: S&P Global Market Intelligence.